Background:
- Cervical Cancer (CC) is a heterogenous disease with multiple histological sub-types.
- Early screening has led to a significant reduction in disease related mortality, but a significant number of patients present with or progress to advanced disease.
- Studies between the molecular and immune alterations in CC primaries (CCP) and CC metastases (CCM) are needed to interrogate potential therapeutic strategies.